MethylHex 42none

Other Combinations

Brand: SEI Pharmaceuticals

CapsuleOther CombinationsOff Market
Click to view full label

Net Contents

60 Capsule(s)

Serving Size

1 Capsule(s)

Servings Per Container

Not specified

Supplement Form

Capsule

Bar Code (UPC/SKU)

1 85427 91260 7

Product Version

Not Present

Label Analysis

Objective insights generated automatically from the official DSLD label — a quick, factual read of how this product is formulated and disclosed.

1Active Ingredients

Single-ingredient formula listed in Supplement Facts.

100%Amount Transparency

Label includes a proprietary blend, so some individual amounts are not itemized.

This analysis is generated algorithmically from label data for educational reference only. It is not a product endorsement, ranking, or medical advice.

Supplement Facts

Serving Size: 1 Capsule(s) · 2 per day

IngredientAmount Per Serving
PROPRIETARY BLEND(3,7-Dihydro-3, 7-Dimethyl-1H-Purine, 6-Dione, Bacopa monnieri, Beta-Alanine, Caffeine Anhydrous, Capsicum, Choline Bitartrate, Corynanthe extract, D-Aspartic Acid, DMAE, Green Tea, GUANIDINO PROPIONIC ACID, HORDENINE, Kola Nut, L-Alanine, PILOCARPUS PENNATIFOLIUS, SODIUM PYRUVATE, White Willow, Yerba Mate)206 mg

Not Present

Other Ingredients

Dibasic Calcium PhosphateMicrocrystalline CelluloseGelatinStearic AcidMagnesium StearateSilicon DioxideRed #3BLUE #1Titanium Dioxide

Target Groups

Adult (18 - 50 Years)

Label Claims

All OtherStructure/Function

Directions & Suggested Use

Suggested/Recommended/Usage/Directions

DIRECTION FOR USE AS A DIETARY SUPPLEMENT: TAKE 1 CAPSULE IN THE MORNING. TAKE 1 CAPSULE MID AFTERNOON. DO NOT EXCEED 2 CAPSULES DAILY.

Warnings & Precautions

Precautions re: All Other

CONSULT A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL BEFORE USING THIS PRODUCT IF YOU HAVE, ARE AT RISK FOR, OR HAVE A FAMILY HISTORY OF STROKE, HEART DISEASE, THYROID DISEASE, LIVER DISEASE, KIDNEY DISEASE, ULCER, DIABETES, HIGH BLOOD PRESSURE, CAFFEINE SENSITIVITY, RECURRENT HEADACHES, ANXIETY, DEPRESSION OR OTHER PSYCHIATRIC CONDITION, GLAUCOMA, DIFFICULTY URINATING, PROSTATE ENLARGEMENT, SEIZURE DISORDER, OR IF YOU ARE USING ANY OTHER DIETARY SUPPLEMENT OR A MONOAMINE OXIDASE INHIBITOR (MAOI), PRESCRIPTION DRUG, ASPIRIN, BLOOD-THINNING MEDICATION OR OVER-THE-COUNTER DRUG CONTAINING EPHEDRINE OR PSEUDOEPHEDRINE (FOUND IN SOME ALLERGY, ASTHMA AND COUGH/COLD PRODUCTS). DO NOT EXCEED RECOMMENDED SERVING. INDIVIDUALS WHO EXCEED THE RECOMMENDED SERVING OR CONSUME CAFFEINE WITH THIS PRODUCT MAY EXPERIENCE SERIOUS ADVERSE HEALTH EFFECTS, INCLUDING MUSCLE FUNCTION LOSS, CHILLS AND VERTIGO. STOP USE AND CALL A PHYSICIAN OR LICENSED QUALIFIED HEALTH CARE PROFESSIONAL IMMEDIATELY IF YOU EXPERIENCE RAPID HEARTBEAT, NAUSEA, INSOMNIA, DIZZINESS, SEVERE HEADACHE, SHORTNESS OF BREATH, OR SIMILAR SYMPTOMS. IN CASE OF OVERDOSE SEEK PROFESSIONAL ASSISTANCE OR CONTACT A POISON CONTROL CENTER IMMEDIATELY. AVOID ALCOHOL AND FOODS WITH TYRAMINE (SUCH AS CHEESE, RED WINE AND LIVER) WHILE TAKING THIS PRODUCT. EXCEEDING RECOMMENDED SERVING WILL NOT IMPROVE RESULTS.

Precautions re: Pregnant or Nursing or Prescription Medications

DO NOT USE IF YOU ARE PREGNANT OR NURSING.

Precautions re: Children

WARNING: NOT RECOMMENDED FOR USE BY MINORS.

Precautions re: Allergies

DO NOT USE IF YOU ARE ALLERGIC OR CONTRAINDICATED TO ASPIRIN.

Precautions re: All Other

DISCONTINUE USE TWO WEEKS PRIOR TO SURGERY OR IF UPSET STOMACH OCCURS.

Precautions re: Children

KEEP OUT OF REACH OF CHILDREN.

Formulation

Formula re: Contains

With DMAE and Pyruvate

FDA Statements

FDA Disclaimer Statement

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

FDA Statement of Identity

DIETARY SUPPLEMENT

Other Label Statements

General Statements: All Other Content

Professional Series

General Statements: All Other Content

Weight Loss Focus, Energy, Clarity

Seals/Symbols

(QRC Code)

General Statements: All Other Content

MADE IN USA

General Statements: All Other Content

Find us on: (f) facebook.com/SEI.Nutrition

Brand IP Statement(s) re: (c), (TM), (SM)

SEI ELEVATE YOUR PERFORMANCE(TM)

General Statements: All Other Content

206 MG

Brand IP Statement(s) re: (c), (TM), (SM)

(C) 2012 SEI PHARMACEUTCIALS, INC.

Manufacturer & Distributor

Distributor

SEI PHARMACEUTICALS

MIAMI, FL, 33142

Other

1.800.808.8800

Where to Buy Locally

Enter your city or ZIP code to find supplement & health stores in your area that may carry this product.

Showing representative supplement & health retailers — search above for stores in your area.

Research & Studies

  • Availability of DMAA supplements despite US Food and Drug Administration action

    PJ Gregory - JAMA internal medicine, 2013 - jamanetwork.com

    … 1 IntheUnitedStates, itiscurrentlymarketed as a dietary supplement, primarily in products promoted as a preworkout supplement for boosting strength, energy, andpower. …

    20137 citations
  • The Impact of black seeds (Nigella sativa) on inflammatory biomarkers–an aspect on insights of clinical and preclinical data

    NMP Maideen - Pharmacol Discov, 2025 - researchgate.net

    … sativa supplementation raised serum levels of hs-CRP, ALT, AST, and FPG, according to a meta-analysis that analyzed RCTs involving 358 NAFLD patients [42]. Furthermore, a meta-…

    20252 citations
  • The pharmacological activities of Cuminum cyminum-A review

    AE Al-Snafi - IOSR Journal of pharmacy, 2016 - researchgate.net

    … Organization (WHO) estimates that 4 billion people, 80 percent of the world population, presently use herbal medicine for some aspect of primary health care(1). Plant showed wide …

    2016331 citations
  • Max-Planck-Institut für Kohlenforschung

    S von Eninen, J Willwacher - eldorado.tu-dortmund.de

    … Diskussionen sei allen aktuellen und ehemaligen Mitarbeitern gedankt; insbesondere möchte … serve the pharmaceutical industry as lead structures for the development of novel drugs. …

  • Enantioinversion in der Gold (I)-katalysierten Hydroalkoxylierung von Allenen & Studien zur Totalsynthese von Chagosensine

    MK Ilg - Chem. Eur. J, 2016 - eldorado.tu-dortmund.de

    … Ihnen sei diese Arbeit gewidmet. … larger quantities for structure–activity relationship studies and eventually medical use.[61b] Their total … As a supplement, the primary …

    2016
  • 1. Non-canonical Atropisomerism in Natural Products: Total Synthesis of Tryptorubin A. 2. Electrosynthesis at Extreme Potentials: New Methods for Forming …

    SH Reisberg - 2021 - search.proquest.com

    [Chapter 1] Tryptorubin A is a hexapeptidic indole alkaloid that was isolated by Clardy and coworkers in 2017. While no apparent bioactivity of the tryptorubins is known, we were …

    2021

Data sourced from the U.S. National Institutes of Health, Office of Dietary Supplements Dietary Supplement Label Database (DSLD) · Label entered 2012-10-25. DSLD Label ID: 12552. This information is provided for educational reference only and is not medical advice. Always follow the product label and consult a doctor or pharmacist before use.